| Name | Cefpirome |
|---|---|
| Synonyms |
5H-1-Pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-cboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-6,7-dihydro-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))
HR-810 (6R,7R)-7-[[(2E)-2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-cboxylate cefpirome sulfate sterile CEFPIROME Cefpiromum [latin] Cefpirome-13C-D3 Cerfpirome 3-[(2,3-cyclopenteno-1-pyridinium)methyl]-7-[2-syn-methoxyimino-2-(2-aminothiazol-4-yl)acetamido]ch-3-em-4-cboxylate (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-cboxylate (6R,7R)-7-(-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-8-oxo-3-(2beta-trimethylenpyridinio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-cboxylat Cefpirome //BP Keitim 1-[[(6R,7R)-7-[2-(2-amino-4-thiazolyl)glyoxylamido]-2-cboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-6,7-dihydro-5H-1-pyrindinium hydroxide, inner salt, 72-(Z)-(O-methyloxime) Cefpiroma [spanish] 1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamino)-2-cboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-6,7-dihydro-5H-1-pyridinium hydroxide, inner salt 5H-1-Pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-cboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-5,6,7,8-tetrahydro-, hydroxide, inner salt, (6R-(6alpha,7beta(Z))) Cefpiroma Cefpiromum CEFPIROME SULPHATE Sinomenine Solution, 100ppm |
| Description | Cefpirome (HR 810) is a fourth generation cephalosporin. Cefpirome shows antibacterial activity. Cefpirome also has in vitro activity against Streptococcus pneumoniae[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H22N6O5S2 |
|---|---|
| Molecular Weight | 514.57700 |
| Exact Mass | 514.10900 |
| PSA | 207.46000 |
| Hazard Codes | Xi: Irritant; |
|---|---|
| Risk Phrases | R36/37/38;R42/43 |
| Safety Phrases | S22-S26-S36/37/39 |
| HS Code | 3003201900 |
|
~%
84957-29-9 |
| Literature: Arzneimittel-Forschung/Drug Research, , vol. 33, # 8 p. 1084 - 1086 |
|
~%
84957-29-9 |
| Literature: Arzneimittel-Forschung/Drug Research, , vol. 33, # 8 p. 1084 - 1086 |
|
~%
84957-29-9 |
| Literature: Journal of Medicinal Chemistry, , vol. 33, # 8 p. 2114 - 2121 |
|
~%
84957-29-9 |
| Literature: Synthetic Communications, , vol. 41, # 5 p. 629 - 636 |
|
~%
84957-29-9 |
| Literature: Synthetic Communications, , vol. 41, # 5 p. 629 - 636 |
|
~%
84957-29-9 |
| Literature: Synthetic Communications, , vol. 41, # 5 p. 629 - 636 |
|
~%
84957-29-9 |
| Literature: Synthetic Communications, , vol. 41, # 5 p. 629 - 636 |
|
~%
84957-29-9 |
| Literature: Journal of Medicinal Chemistry, , vol. 33, # 8 p. 2114 - 2121 |
|
~%
84957-29-9 |
| Literature: Arzneimittel-Forschung/Drug Research, , vol. 33, # 8 p. 1084 - 1086 |
| Precursor 5 | |
|---|---|
| DownStream 3 | |
| HS Code | 3003201900 |
|---|